COVID antibody firm Abingdon Health tests £100m float | Bala
12298
post-template-default,single,single-post,postid-12298,single-format-standard,ajax_fade,page_not_loaded,,qode_grid_1200,qode-theme-ver-16.7,qode-theme-bridge,wpb-js-composer js-comp-ver-5.5.4,vc_responsive

COVID antibody firm Abingdon Health tests £100m float

16 Nov COVID antibody firm Abingdon Health tests £100m float

Posted at 12:35h in Articles by

The company enlisted by the government to lead the Rapid Test Consortium as part of its response to the coronavirus pandemic will decide this week whether to pursue a London stock market flotation.

Print page


Generated by Feedzy